Microbot Medical® Aligns with Recently Adopted Policy of the Largest U.S.-Based Medical Association to Expand Protection for Healthcare Professionals from Ionizing Radiation

Microbot believes that this guidance underscores the growing need for solutions that enhance safety in interventional procedures, creating meaningful opportunities for technologies like LIBERTY. The ...

Microbot Medical® Confirms Continued Operational and Commercial Stability Amid Current Geopolitical Event

Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY ® Endovascular Robotic System, announced today that the Company, both in the USA and in Israel, is not ...

Tampa General Hospital is the First Health System in Florida to Adopt the LIBERTY® Endovascular Robotic System

Early Post-Clearance Momentum Signals Accelerated Hospital Adoption of Advanced RoboticsHINGHAM, Mass., Feb. 24, 2026 (GLOBE ...
WGN Radio

Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the LIBERTY® Endovascular Robotic System

HINGHAM, Mass., April 09, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY ® Endovascular Robotic System, presented for the first time the data from ...
Nasdaq

Microbot Medical Inc. Appoints Michal Ahuvia as Director of Operations to Enhance Production for LIBERTY® Launch

Microbot Medical Inc. has appointed Ms. Michal Ahuvia as the new Director of Operations to enhance production and efficiency ahead of the commercial launch of their LIBERTY® Endovascular Robotic ...
Nasdaq

Microbot Medical Inc. Announces Registered Direct Offering and Concurrent Private Placement Totaling Approximately $13 Million

Microbot Medical Inc. announces a direct offering of common stock and a concurrent private placement, raising approximately $13 million. Microbot Medical Inc. announced a registered direct offering ...
Seeking Alpha

Microbot Medical Appoints Seasoned Medical Expert Dr. Juan Diaz- Cartelle as its New Chief Medical Officer in Anticipation of Its Clinical, Regulatory and Commercial Activities

BRAINTREE, Mass., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (MBOT), developer of the innovative LIBERTY ® Endovascular Robotic Surgical System, today announced the appointment of Dr.
Seeking Alpha

Microbot Medical Announces $1.5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

HINGHAM, Mass., June 02, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (MBOT) today announced that it has entered into definitive agreements for the purchase and sale of 701,756 shares of the Company ...
Hosted on MSN

Microbot Medical (MBOT) Upgraded to Buy: What Does It Mean for the Stock?

Microbot Medical Inc. (MBOT) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which ...
MarketWatch

REMINDER: Microbot Medical to Highlight FDA 510(k) Clearance of the LIBERTY Endovascular Robotic System at the H.C. Wainwright Annual Investor Conference

The MarketWatch News Department was not involved in the creation of this content. HINGHAM, Mass., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and manufacturer of ...
The National Law Review

Microbot Medical Closes $13 Million Registered Direct Offering

BRAINTREE, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced the closing of its previously announced registered direct offering priced at-the-market under ...

Microbot Medical®’s LIBERTY® Endovascular Robotic System Highlighted at a Leading Vascular Disease Management Conference

Detailed price information for Microbot Medical Inc (MBOT-Q) from The Globe and Mail including charting and trades.